Trial intelligence / Profile preview

RIVIERA trial of ivabradine in acute coronary syndrome

2009-010832-17Phase 4Active

Sponsor
Dr. Francisco Bosa Ojeda
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in acute coronary syndrome (ACS) comparing Ivabradine with Placebo (2 arms). Primary endpoints: High-sensitivity C-reactive protein, Soluble CD40 ligand and 4 more. Started Apr 2009; status: active.

02

Drugs

ivabradine
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on 2009-010832-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010832-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call